The Neuro-Inflammation Link: Is Your Brain “On Fire”?

ByRohan Smith

The Neuro-Inflammation Link: Is Your Brain On Fire?

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Chronic low-grade inflammation may contribute to depression by activating the kynurenine pathway, an enzyme cascade that diverts the amino acid tryptophan away from serotonin production and toward neurotoxic metabolites such as quinolinic acid. This immune-driven biochemical shift, mediated by pro-inflammatory cytokines including interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), has been associated with low mood, fatigue, cognitive slowing, and reduced motivation (1,2,5,8).

At a Glance

  • Pro-inflammatory cytokines such as IL-6 and TNF-alpha can activate the enzyme indoleamine 2,3-dioxygenase (IDO), shunting tryptophan into the kynurenine pathway and away from serotonin synthesis (1,5).
  • Elevated quinolinic acid, a kynurenine metabolite and NMDA-receptor agonist, has been linked to excitotoxic stress in mood-regulating brain regions including the hippocampus (18,20).
  • High-sensitivity C-reactive protein (hs-CRP) levels above approximately 1.0 mg/L have been associated with increased risk of depressive symptoms in population-level research (2,11).
  • Curcumin, omega-3 fatty acids (EPA/DHA), and saffron (Crocus sativus) are evidence-informed botanical and nutritional agents that may modulate neuro-inflammatory pathways (10,13,17).
  • Organic Acids Testing (OAT) can measure kynurenic and quinolinic acid levels, helping to clarify whether tryptophan metabolism is favouring the inflammatory kynurenine pathway (1,21).

Within the Adelaide functional medicine community, there is growing recognition that the traditional “chemical imbalance” model of depression is incomplete. A growing body of research, including landmark work by Andrew H. Miller and Charles L. Raison published in Nature Reviews Immunology, suggests that, in a subset of individuals, depressive symptoms are associated with immune activation and chronic, low-grade inflammation. Neuroinflammation depression in Adelaide is linked to the kynurenine pathway, which plays a crucial role in mood regulation, inflammation, and mental health disorders like depression. At Elemental Health and Nutrition, mood concerns are explored through an inflammatory and metabolic lens, particularly when standard approaches have provided limited relief. This perspective aligns with broader work in neuro-inflammation and mood disorders.

The Kynurenine Pathway: How Inflammation Diverts Serotonin Production

Indoleamine 2,3-dioxygenase (IDO), the rate-limiting enzyme of the kynurenine pathway, is up-regulated by pro-inflammatory cytokines during periods of physiological or psychological stress, including infection, gut dysbiosis, or prolonged psychosocial stress (1,5).

Mechanism Description Key References
IDO Enzyme Activation Pro-inflammatory cytokines, including IL-6 and TNF-alpha, activate indoleamine 2,3-dioxygenase (IDO), increasing the conversion of tryptophan into kynurenine (1,5)
Tryptophan Diversion Under inflammatory conditions, supplemental tryptophan or 5-HTP may be preferentially metabolised along the kynurenine pathway rather than toward serotonin synthesis (12,17)
Excitotoxic Stress Elevated quinolinic acid, an NMDA-receptor agonist, has been linked to excitotoxic stress and structural vulnerability in mood-regulating brain regions such as the hippocampus (18,20)

Sickness Behaviour vs. Persistent Low Mood

Sickness behaviour is an evolutionarily conserved adaptive response, first characterised by researchers including Robert Dantzer and Keith W. Kelley, that promotes rest and energy conservation during acute illness (2,5,9). Difficulties arise when inflammatory signalling becomes chronic rather than time-limited.

  • Anhedonia: Inflammatory mediators have been shown to interfere with dopaminergic reward pathways in the basal ganglia, contributing to reduced pleasure and motivation. Research by Lucile Capuron and colleagues demonstrated altered dopaminergic responses in inflammation-associated depression (16,19).
  • Neuro-Fatigue: Inflammation can impair mitochondrial energy metabolism, a process explored in Robert K. Naviaux’s Cell Danger Response model, which may contribute to cognitive fatigue and mental exhaustion. This pattern commonly overlaps with presentations seen in chronic fatigue and post-viral syndromes (15,22).

Inflammatory Biomarker Mapping in Adelaide Functional Medicine

Objective biomarkers, rather than symptoms alone, are used to explore potential inflammatory contributors to mood symptoms in clinical practice.

Biomarker Clinical Significance Key References
hs-CRP (High-Sensitivity C-Reactive Protein) A marker of systemic inflammation; levels above approximately 1.0 mg/L have been associated with increased risk of depressive symptoms in population studies (2,11)
Homocysteine Elevated levels may reflect impaired methylation capacity and have been linked to neuro-inflammatory processes (12,15)
Organic Acids Testing (OAT) Measurement of kynurenic and quinolinic acid via Organic Acids Testing (OAT) can help determine whether tryptophan metabolism is favouring the kynurenine pathway (1,21)

Botanical and Nutritional Anti-Inflammatory Support

Evidence-informed nutritional and botanical strategies may be considered as part of a broader, individualised care plan when inflammation appears to be a contributing factor to mood disturbance.

Intervention Mechanism of Action Key Evidence
Curcumin (Phytosome formulations) Demonstrates central nervous system activity and has been shown to influence inflammatory signalling pathways, including those involved in IDO activation Meta-analyses by Adrian L. Lopresti et al. and Qi Xiang Ng et al. (10,20)
Omega-3 Fatty Acids (EPA/DHA) Higher EPA intake has been associated with reduced inflammatory signalling and modulation of microglial activity Janice K. Kiecolt-Glaser et al. clinical trial (13,19)
Saffron (Crocus sativus) Clinical trials suggest saffron may improve symptoms in mild-to-moderate depression via antioxidant and anti-inflammatory effects Hausenblas et al. meta-analysis (17,21)

Next Steps

  1. Assess inflammatory markers: Request hs-CRP and homocysteine testing to establish your baseline inflammatory status and identify potential contributors to mood symptoms.
  2. Explore the kynurenine pathway: An Organic Acids Test (OAT) can reveal whether tryptophan metabolism is being diverted away from serotonin production.
  3. Address inflammatory drivers: Work with a practitioner to identify and address root causes of inflammation, including gut health, diet, and chronic stress.

Frequently Asked Questions

Can diet influence brain inflammation?
Yes. Diets high in ultra-processed foods and refined sugars are associated with increased gut permeability and endotoxin exposure, which may promote systemic and neuro-inflammatory responses (7,14,22).
Why don’t antidepressants work for everyone?
Elevated inflammatory markers, such as CRP above approximately 3.0 mg/L, have been associated with reduced response rates to SSRIs in some individuals. SSRIs primarily influence serotonin reuptake and do not directly address inflammatory diversion of tryptophan metabolism (2,6,18).
How long does it take to influence neuro-inflammation?
While dietary and lifestyle changes can affect inflammatory signalling relatively quickly, measurable changes in kynurenine metabolites and symptom patterns often occur over several weeks when interventions are maintained (10,20).

Key Insights

  • Depressive symptoms are frequently associated with chronic, low-grade inflammation (2,4)
  • The kynurenine pathway provides a biological framework linking inflammation and serotonin depletion (1,5)
  • Neuro-inflammation has been linked to structural and functional changes in mood-regulating brain regions (18,20)
  • Biomarkers such as hs-CRP and kynurenine metabolites can help clarify inflammatory contributions to mood symptoms (2,21)

Citable Takeaways

  1. Pro-inflammatory cytokines including IL-6 and TNF-alpha activate the enzyme indoleamine 2,3-dioxygenase (IDO), diverting tryptophan from serotonin synthesis into the kynurenine pathway (Schwarcz et al., Nature Reviews Neuroscience, 2012; Dantzer et al., Nature Reviews Neuroscience, 2008).
  2. High-sensitivity C-reactive protein (hs-CRP) levels above approximately 1.0 mg/L have been associated with increased risk of depressive symptoms in population studies (Miller et al., Nature Reviews Immunology, 2016; Raison et al., JAMA Psychiatry, 2013).
  3. Elevated quinolinic acid, an NMDA-receptor agonist and kynurenine pathway metabolite, has been linked to excitotoxic stress in mood-regulating brain regions including the hippocampus (Haroon et al., Molecular Psychiatry, 2016).
  4. Meta-analyses suggest curcumin may reduce depressive symptoms, with proposed mechanisms including modulation of IDO activation and inflammatory signalling (Lopresti et al., Journal of Affective Disorders, 2014; Ng et al., JAMDA, 2017).
  5. CRP levels above approximately 3.0 mg/L have been associated with reduced response rates to SSRIs, suggesting inflammation-driven depression may require alternative therapeutic strategies (Miller et al., Nature Reviews Immunology, 2016; Kohler et al., JAMA Psychiatry, 2014).
  6. Organic Acids Testing (OAT) can measure kynurenic and quinolinic acid levels, providing objective data on whether tryptophan metabolism is being diverted through the inflammatory kynurenine pathway (Schwarcz et al., 2012; O’Mahony et al., Behavioural Brain Research, 2015).

Uncover the Inflammation Behind Your Mood

If low mood, brain fog, or fatigue persist despite conventional approaches, inflammation may be a hidden contributor. At Elemental Health and Nutrition, we use advanced functional testing to assess inflammatory pathways and develop personalised strategies that address root causes rather than symptoms alone.

Book an Appointment

References

  1. Schwarcz R et al. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012 Jul 18;13(8):546-58. https://doi.org/10.1038/nrn3257
  2. Miller AH et al. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016 Jan;16(1):22-34. https://doi.org/10.1038/nri.2015.5
  3. Khandaker GM et al. Association of serum interleukin 6 and C-reactive protein with depression. JAMA Psychiatry. 2014 Oct;71(10):1121-8. https://doi.org/10.1001/jamapsychiatry.2014.1333
  4. Setiawan E et al. Role of neuroinflammation in major depressive disorder. JAMA Psychiatry. 2015 Aug;72(8):803-11. https://doi.org/10.1001/jamapsychiatry.2015.0764
  5. Dantzer R et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008 Jan;9(1):46-56. https://doi.org/10.1038/nrn2297
  6. Kohler O et al. Effect of anti-inflammatory treatment on depression. JAMA Psychiatry. 2014 Dec;71(12):1381-91. https://doi.org/10.1001/jamapsychiatry.2014.1611
  7. Felger JC et al. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013 Aug 29;246:199-229. https://doi.org/10.1016/j.neuroscience.2013.04.060
  8. Slavich GM et al. From stress to inflammation and major depressive disorder. Psychol Bull. 2014 May;140(3):774-815. https://doi.org/10.1037/a0035302
  9. Kelley KW et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003 Feb;17 Suppl 1:S112-8. https://doi.org/10.1016/s0889-1591(02)00072-3
  10. Lopresti AL et al. Curcumin for major depressive disorder: a meta-analysis. J Affect Disord. 2014 Oct;167:368-75. https://doi.org/10.1016/j.jad.2014.06.001
  11. Raison CL et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression. JAMA Psychiatry. 2013 Jan;70(1):31-41. https://doi.org/10.1001/2013.jamapsychiatry.4
  12. Myint AM et al. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007 Apr;98(3):143-51. https://doi.org/10.1016/j.jad.2006.07.013
  13. Kiecolt-Glaser JK et al. Omega-3 supplementation lowers inflammation and anxiety in medical students. Brain Behav Immun. 2011 Nov;25(8):1725-34. https://doi.org/10.1016/j.bbi.2011.07.229
  14. Dash S et al. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 2015 Jan;28(1):1-6. https://doi.org/10.1097/YCO.0000000000000117
  15. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014 May;16:7-17. https://doi.org/10.1016/j.mito.2013.08.006
  16. Capuron L et al. Dopaminergic mechanisms of reduced basal ganglia responses to food rewards in depression. Mol Psychiatry. 2012 Mar;17(3):327-36. https://doi.org/10.1038/mp.2010.147
  17. Hausenblas HA et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis. J Integr Med. 2013 Nov;11(6):377-83. https://doi.org/10.3736/jintegrmed2013056
  18. Haroon E et al. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry. 2016 Oct;21(10):1351-7. https://doi.org/10.1038/mp.2015.206
  19. Pariante CM. Why are depressed patients inflamed? Eur Neuropsychopharmacol. 2017 Jun;27(6):554-559. https://doi.org/10.1016/j.euroneuro.2017.02.006
  20. Ng QX et al. Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc. 2017 Jul 1;18(7):628-633. https://doi.org/10.1016/j.jamda.2017.03.009
  21. O’Mahony SM et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015 Feb 15;277:32-48. https://doi.org/10.1016/j.bbr.2014.07.027
  22. Lord RS, Bralley JA. Laboratory evaluations for integrative and functional medicine. 2nd ed. Duluth, GA: Metametrix Institute; 2008.

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *